Covered recipient · General Payments record
ERIKA ANN WEEKS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2022–2024
$857.70
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $299.99 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $146.77 | 8 |
| Lilly USA, LLC | $43.43 | 3 |
| Acerta Pharma LLC | $37.66 | 2 |
| Amgen Inc. | $27.75 | 2 |
| Exact Sciences Corporation | $15.57 | 1 |
| Abbott Laboratories | $15.46 | 1 |
| ABBVIE INC. | $13.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $15.46 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125295392 | CMS |
| ABBVIE INC. | $13.35 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390759 | CMS |
| Amgen Inc. | $14.36 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117715228 | CMS |
| Amgen Inc. | $13.39 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117715230 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.68 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104326080 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.98 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105613353 | CMS |
| Exact Sciences Corporation | $15.57 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114425004 | CMS |
| Lilly USA, LLC | $14.53 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135665866 | CMS |
| Lilly USA, LLC | $14.99 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135664029 | CMS |
| Lilly USA, LLC | $13.91 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135682251 | CMS |
| Novo Nordisk Inc | $12.88 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100504977 | CMS |
| Novo Nordisk Inc | $21.14 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100374351 | CMS |
| Novo Nordisk Inc | $15.62 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100274636 | CMS |
| Novo Nordisk Inc | $18.98 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100345812 | CMS |
| Novo Nordisk Inc | $18.94 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100548700 | CMS |
| Novo Nordisk Inc | $15.56 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100565742 | CMS |
| Novo Nordisk Inc | $22.22 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100435251 | CMS |
| Novo Nordisk Inc | $21.43 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100315024 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.